CIDRAP newsletters options
Review of 31 studies finds fatigue, memory problems, and shortness of breath are most common.
COVID-19 mRNA vaccine effectiveness (VE) against infection was 5% to 7% higher when the two primary doses were given at least 7 weeks rather than 3 to 5 weeks apart, according to an observational study of hospital and community healthcare workers (HCWs) in British Columbia published late last week in Open Forum Infectious Diseases.
In China, officials say they will help key industries resume operations in Shanghai.
Officials are probing clusters of acute hepatitis in kids, many resulting in liver failure.
Certain psychiatric disorders may predispose fully vaccinated COVID-19 survivors to reinfection.
Rates of upper airway infections (UAIs) such as croup and bacterial tracheitis among pediatric COVID-19 patients, though low, rose after the Omicron variant became dominant in December 2021, with more than one fifth of hospitalized children with both conditions developing severe illness, estimates a study today in JAMA Pediatrics.
Data from the Wellcome Monitor survey of UK citizens reveal that negative views of vaccination are tied to having poor knowledge about the role of antibiotics for treating infections, according to a study today in Vaccine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Compared with a third dose, fourth-dose protection was 64% against severe disease and 76% against death.
Data suggest 4CMenB protection against gonorrhea and support the feasibility of a gonococcal vaccine.
In Shanghai, officials maintain no one has died from Omicron—an assertion being challenged.
In its first evaluation of COVID-19 exposures among US healthcare professionals (HCPs) over the first year of the pandemic, the Centers for Disease Control and Prevention (CDC) reports that most HCPs were likely infected at work rather than in the community.
The CDC extends the mask order for public transit by 2 weeks and revamps international travel alerts.
Cefiderocol and ceftazidime-avibactam were selected to be part of a novel pilot project.
COVID-19 exposed existing US public health weaknesses, especially along racial lines.
Two new studies describe benefits of the monoclonal antibody (mAb) treatment casirivimab-imdevimab in adult COVID-19 outpatients, both suggesting lower rates of hospitalization, intensive care unit (ICU) admission, and death in an era dominated by the Delta variant.
A large-scale analysis reveals that the prevalence of antimicrobial resistance (AMR) has remained stable for Campylobacter in the United States and United Kingdom in recent years, suggesting that antibiotic stewardship efforts have not made a large impact, according to a new study in Antimicrobial Agents and Chemotherapy.
Researchers say 44% of the population was infected by November 2021, with wide regional variations.
Cases are rising in eastern states where BA.2 subvariant proportions are very high. Globally, COVID cases passed the 500 million mark today.
Recent evidence shows one-dose regimens perform just as well as two- or three-dose schedules.
